pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 6,918 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
  • Preclinical
    IMM-004
    Sickle Cell Disease IMMvention Therapeutix Inc
  • Phase 2
    IMM-124E
    Travelan
    Traveler's Diarrhea$IMRN Immuron Ltd
  • Preclinical
    IMM-4701
    Triple-Negative Breast Cancer (TNBC) ImmuneOnco Biopharmaceuticals (Shanghai) Co Ltd
  • Phase 2
← prev
page 95 of 231
next →
131
Pain89
Neurology1
IMM01-STEM
Muscle Atrophy
Immunis Inc
  • Phase 3
    IMNN-001
    Epithelial Ovarian Cancer$IMNN Imunon, Inc.
  • Phase 2
    IMNN-101
    Coronavirus Disease 2019 (COVID-19)$IMNN Imunon, Inc.
  • Phase 2
    IMP-1734
    Fallopian Tube Cancer$EIKN Eikon Therapeutics, Inc.
  • Phase 2
    IMP-9064
    Solid Tumor IMPACT Therapeutics Inc
  • Phase 2
    IMS-001
    Primary Progressive Multiple Sclerosis (PPMS) Imstem Biotechnology Inc
  • Phase 2
    IMT-009
    Burkitt Lymphoma Immunitas Therapeutics Inc
  • Preclinical
    IMTV-014
    Human Immunodeficiency Virus (HIV) Infections (AIDS) Immgenuity Inc
  • Phase 2
    IMU-131
    Gastric Cancer Imugene Ltd
  • Phase 1
    IN-001
    Herpes Zoster (Shingles) Innorna Co Ltd
  • Preclinical
    IN-002
    Respiratory Syncytial Virus (RSV) Infections Inhalon Biopharma Inc
  • Preclinical
    IN-003
    Human Metapneumovirus Infections Inhalon Biopharma Inc
  • Preclinical
    IN-015
    Progressive Familial Intrahepatic Cholestasis Innorna Co Ltd
  • Preclinical
    IN-022
    Homocystinuria Innorna Co Ltd
  • Phase 1
    INB-100
    Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leuk…$INAB IN8BIO, INC.
  • Phase 1
    INB-200
    Glioblastoma Multiforme (GBM)$INAB IN8BIO, INC.
  • Preclinical
    INB-619
    Systemic Lupus Erythematosus$INAB IN8BIO, INC.
  • Phase 1
    INCA-033989
    Essential Thrombocythemia$INCY INCYTE CORP
  • Phase 1
    INCB-100658
    Chronic Idiopathic Myelofibrosis (Primary Myelofibrosis)$INCY INCYTE CORP
  • Preclinical
    IND-30496
    Alzheimer's Disease Nuravax Inc
  • INDIUM DTPA IN 111
    INDIUM DTPA IN 111 (INDIUM IN-111 PENTETATE DISODIUM)
    no indication GE HEALTHCARE
  • INDIUM IN 111 OXYQUINOLINE
    INDIUM IN 111 OXYQUINOLINE (INDIUM IN-111 OXYQUINOLINE)
    no indication GE HEALTHCARE
  • INDOCYANINE GREEN
    INDOCYANINE GREEN (INDOCYANINE GREEN AND WATER)
    no indication RENEW PHARMS
  • INFUVITE PEDIATRIC
    INFUVITE PEDIATRIC (MULTIPLE VITAMINS INJECTION)
    no indication SANDOZ CANADA INC
  • Phase 2
    INKmune
    INKmune
    Metastatic Castration-Resistant Prostate Cancer (mCRPC)$INMB Inmune Bio, Inc.
  • INLEXZO
    INLEXZO (GEMCITABINE INTRAVESICAL)
    no indication JANSSEN BIOTECH
  • Phase 3
    INM-004
    Typical Hemolytic Uremic Syndrome (Shiga-Toxin Associated… Inmunova SA